MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Dietary Vitamin E as a protective factor for Parkinson’s Disease: a clinical and experimental study

    T. Schirinzi, G. Martella, P. Imbriani, G. Di Lazzaro, M. Alwardat, M. Pierantozzi, N. Mercuri, A. Pisani (Rome, Italy)

    Objective: To test if a higher dietary intake of Vitamin E might represent a protective factor in Parkinson’s disease (PD). Background: Effective disease-modifying treatments are…
  • 2019 International Congress

    Longitudinal Cortical Changes Associated with Apathy in Parkinson’s Disease

    E. Canu, F. Agosta, F. Imperiale, T. Stojković, I. Stankovic, S. Basaia, A. Fontana, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To follow clinical/cognitive and cortical thickness (CT) changes in Parkinson’s disease (PD) patients with stable apathy (PD-sAp), without apathy (PD-noAp), and patients who developed…
  • 2019 International Congress

    Non-motor Symptoms in Hyperkinetic Movement Disorders

    H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)

    Objective: To evaluate the frequencies and clinical features of non-motor symptoms in several different hyperkinetic movement disorders and compare them with the healthy age- and…
  • 2019 International Congress

    Relationship between RBD and olfactory disorder, clinical symptoms in Parkinson’s disease

    M. Iijima, F. Yoshi, K. Suzuki, S. Nogawa, T. Osada, H. Hirata, K. Kitagawa, N. Hattori, Y. Okuma (Tokyo, Japan)

    Objective: We aimed to assess the association among RBD, olfactory function and clinical symptoms in patients with Parkinson's disease (PD). Background: Rapid eye movement sleep…
  • 2019 International Congress

    Speech and swallowing disorders in Parkinson’s disease – is there a link?

    N. Madetko, S. Budrewicz (Wrocław, Poland)

    Objective: To determine: 1.If acoustic speech analysis can be a method of oropharyngeal dysphagia detection. 2.Which acoustic parameters and to what extent correlate with fiberoptic…
  • 2019 International Congress

    Evidence of altered Serotonergic Network in Parkinson’s disease by using a multi-modal MRI and PET imaging approach

    SP. Caminiti, Z. Chappell, A. Carotenuto, G. Dervenoulas, T. Yousaf, G. Pagano, H. Wilson, M. Politis (London, United Kingdom)

    Objective: This study aims to assess how serotonergic pathological derangement may produce alterations in Parkinson’s disease (PD) functional connectivity, by means of a multimodal neuroimaging…
  • 2019 International Congress

    Functional connectome in Parkinson’s disease mild cognitive impairment

    M. Delgado-Alvarado, V. Ferrer-Gallardo, I. Navalpotro-Gómez, S. Moia, M. Carreiras, C. Caballero-Gaudes, MC. Rodríguez-Oroz (Torrelavega, Spain)

    Objective: To unravel functional connectivity (FC) traits in Parkinson’s disease mild cognitive impairment (PD-MCI). Background: PD-MCI is a well-known risk factor for PD associated dementia.…
  • 2019 International Congress

    Neural correlates of compensatory process and impaired working memory in Parkinson’s disease during disease progression

    T. Hattori, R. Reynolds, S. Horovitz, G. Chen, C. Lungu, E. Wassermann, M. Hallett (Tokyo, Japan)

    Objective: We aimed to elucidate neural responses associated with working memory (WM) tasks in Parkinson's disease (PD) patients during disease progression. Background: PD patients often…
  • 2019 International Congress

    Diagnostic potential of automated diffusion imaging for the differential diagnosis of multiple system atrophy and Parkinson’s disease

    F. Krismer, V. Beliveau, K. Seppi, G. Goebel, G. Wenning, E. Gizewski, W. Poewe, C. Scherfler (Innsbruck, Austria)

    Objective: To evaluate the diagnostic potential of an automated diffusion imaging (DWI) analyses pipeline in separating patients with multiple system atrophy (MSA) and Parkinson’s disease…
  • 2019 International Congress

    Imaging correlates of impaired self-awareness of cognitive deficits in Parkinson’s disease

    F. Maier, A. Greuel, M. Hoock, M. Tahmasian, F. Jessen, I. Csoti, L. Timmermann, C. Eggers (Cologne, Germany)

    Objective: To discover the neural basis of impaired self-awareness of cognitive deficits (ISA-cog) in Parkinson’s disease (PD) patients with mild cognitive impairment (MCI). Background: Anosognosia…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley